Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Cincor Pharma (CINC)
NASDAQ:CINC
Cincor Pharma (CINC) Stock Price & Analysis
31 Followers
CINC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$10.53 - $43.15
Previous Close$28.79
Volume164.00K
Average Volume (3M)617.08K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)-12.6
Beta-2.37
Next EarningsMar 21, 2023
EPS Estimate-$0.58
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price Target$40.33
EPS (TTM)-2.29
Shares Outstanding43,764,323
R-Squared0.18
Standard Deviation0.33
10 Day Avg. Volume1,367,584
30 Day Avg. Volume617,082
Price to Book (P/B)2.44
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-24.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside39.55% Upside
Rating ConsensusModerate Buy
Alpha-0.00145
Number of Analyst Covering7
Cincor Pharma News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CINC FAQ
What was Cincor Pharma’s price range in the past 12 months?
Cincor Pharma lowest stock price was $10.53 and its highest was $43.15 in the past 12 months.
What is Cincor Pharma’s market cap?
Currently, no data Available
When is Cincor Pharma’s upcoming earnings report date?
Cincor Pharma’s upcoming earnings report date is Mar 21, 2023 which is in 52 days.
How were Cincor Pharma’s earnings last quarter?
Cincor Pharma released its earnings results on Nov 03, 2022. The company reported -$0.51 earnings per share for the quarter, beating the consensus estimate of -$0.609 by $0.099.
Is Cincor Pharma overvalued?
According to Wall Street analysts Cincor Pharma’s price is currently Undervalued.
Does Cincor Pharma pay dividends?
Cincor Pharma does not currently pay dividends.
What is Cincor Pharma’s EPS estimate?
Cincor Pharma’s EPS estimate is -$0.58.
How many shares outstanding does Cincor Pharma have?
Cincor Pharma has 43,764,324 shares outstanding.
What happened to Cincor Pharma’s price movement after its last earnings report?
Cincor Pharma reported an EPS of -$0.51 in its last earnings report, beating expectations of -$0.609. Following the earnings report the stock price went down -14.299%.
Which hedge fund is a major shareholder of Cincor Pharma?
Among the largest hedge funds holding Cincor Pharma’s share is Perceptive Advisors LLC. It holds Cincor Pharma’s shares valued at 109M.
---
Cincor Pharma Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$40.33
$40.33
Blogger Sentiment
Bullish
CINC Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 674.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.7%
Last 30 Days ▼ 9.4%
Last 30 Days ▼ 9.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
69.25%
12-Months-Change
Learn more about TipRanks Smart Score
Company Description
Cincor Pharma
CinCor Pharma Inc is a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases.
---
---